Risk factors for infections in newly diagnosed Multiple Myeloma patients: A Danish retrospective nationwide cohort study
- 29 October 2018
- journal article
- research article
- Published by Wiley in European Journal of Haematology
- Vol. 102 (2), 182-190
- https://doi.org/10.1111/ejh.13190
Abstract
Objectives Infections pose the greatest risk of early death in patients with Multiple Myeloma. However, few studies have analyzed the risk factors for infections in Multiple Myeloma patients. The aim of this study was to analyze the risk factors infections within a population‐based MM cohort. Methods Using Danish registries (from 2005‐2013) we analyzed all ICD‐10 codes for infections within the first 6 months of Multiple Myeloma diagnosis in 2557 patients. Results Pneumonia and sepsis represented 46% of infections. Multivariable regression analysis showed that risk factors for pneumonia were male gender (HR 1,4; p=0,001), ISS II (HR 1,6; p=0,0004) and ISSIII (HR 1,8; p=0,0004) and elevated LDH (HR 2,6; p=0.0008). Risk factors for sepsis were high bone marrow plasma cell % (HR 1,1; p=0,038), ISS II (HR 1,7; p=0,007) ISS III (HR 2,0; p=0,002) and creatinine (HR 2,1; p=0,002). Neither immunoparesis (hypogammaglobulinemia) nor comorbidity was significant risk factors. Conclusions Our study suggests that tumor burden and renal impairment are risk factors for pneumonia and sepsis in the early phase of Multiple Myeloma.Keywords
This publication has 38 references indexed in Scilit:
- Morbidity and mortality in common variable immune deficiency over 4 decadesBlood, 2012
- The frequency of T regulatory cells modulates the survival of multiple myeloma patients: detailed characterisation of immune status in multiple myelomaBritish Journal of Cancer, 2012
- The Danish National Patient RegisterScandinavian Journal of Public Health, 2011
- The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of PatientsBMC Medical Research Methodology, 2011
- Comparative Study of Immune Status to Infectious Agents in Elderly Patients with Multiple Myeloma, Waldenstrom's Macroglobulinemia, and Monoclonal Gammopathy of Undetermined SignificanceClinical and Vaccine Immunology, 2011
- Immunodeficiency and immunotherapy in multiple myelomaBritish Journal of Haematology, 2007
- Early Mortality After Diagnosis of Multiple Myeloma: Analysis of Patients Entered Onto the United Kingdom Medical Research Council Trials Between 1980 and 2002—Medical Research Council Adult Leukaemia Working PartyJournal of Clinical Oncology, 2005
- Primary immunodeficiencies associated with pneumococcal diseaseCurrent Opinion in Allergy and Clinical Immunology, 2003
- Review of 1027 Patients With Newly Diagnosed Multiple MyelomaMayo Clinic Proceedings, 2003
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987